Virtus LifeSci Biotech Products ETF
BBP NYSE Arca
The Fund invests in products stage companies, which are typically more established companies with much clinical trial failure risk behind them.
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 24.5M as of Feb 2020
- Expense ratio
- 0.79% per year
- Dividend yield
- 0.00% Yearly
- Volatility · 1Y
- 25.9% Above Average
- Beta
- 0.81 vs the market
- 52-week range
- 70.97109.90
How BBP has paid off
Price return over every period, and total return with dividends reinvested, set against price alone.
Return by period
Price · to Oct 12Total return vs price return
Price onlyOver 1 year, BBP returned +45.9% with dividends reinvested — dividends added 0.0 pts to the price move.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±26% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −9.4% on Jul 31, 2026 — 22 days after the previous high
More than 5% below a high 23% of the time.
Market sensitivity
BetaA beta of 0.81 means BBP has moved less than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average103.44 +0.2%
- 26-day average103.83 −0.2%
- 50-day average102.80 +0.8%
- 200-day average91.90 +12.8%
The price is above 3 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
Health Care · Biotech — tracking the LifeSci Biotechnology Products Index.
- Assets under management24.5MUSD
- Expense ratio0.79%per year
- Holdings47
- Risk score7.9High
Launched December 2014. Fund data as of Feb 27, 2020.
Where BBP shows up
Curated themes and indices that hold BBP. Open one to see it in context, or test the whole theme in a portfolio.
About Virtus LifeSci Biotech Products ETF
The Fund invests in products stage companies, which are typically more established companies with much clinical trial failure risk behind them.
- Featured in 3 curated themes
- 47 holdings
- Ticker
- BBP
- Exchange
- NYSE Arca
- ISIN
- US26923G2021
- CUSIP
- 26923G202
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Biotech
- Benchmark
- LifeSci Biotechnology Products Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Feb 27, 2020
Put BBP to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.